J. Goldman & Co’s Zimmer Biomet ZBH Stock Holding History

J. Goldman & Co’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-15,759	Closed	-$1.8M	–	343
2015 Q1	$1.8M	Buy	+15,759	New	+$1.8M	0.11%	192

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

J. Goldman & Co's ZBH Position: Q3 2020 in Review

J. Goldman & Co sold out of Zimmer Biomet (ZBH) in Q3 2020, closing a stake of 17,840 shares — an estimated $2.07M sold.

J. Goldman & Co first reported a position in ZBH in Q3 2013 and held it in 8 quarters. The position peaked at $15.5M in Q1 2019. 930 funds tracked by Wall St. Rank hold ZBH as of Q3 2020.

J. Goldman & Co reported no remaining Zimmer Biomet position as of Q3 2020 after selling out during the quarter.
J. Goldman & Co sold 17,840 Zimmer Biomet shares in Q3 2020, an estimated $2.07M.
J. Goldman & Co first reported a position in Zimmer Biomet in Q3 2013 and held it in 8 quarters.
J. Goldman & Co's Zimmer Biomet position peaked at $15.5M in Q1 2019.
930 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2020.

Based on J. Goldman & Co's 13F filing for Q3 2020, filed 16 Nov 2020.